102 related articles for article (PubMed ID: 2074392)
1. [Scanning electron microscopic observation of mouse ascitic carcinoma cells after intraperitoneal administration of lentinan].
Kurokawa T; Tamakuma S
Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2822-7. PubMed ID: 2074392
[TBL] [Abstract][Full Text] [Related]
2. [Scanning electron microscopic observation of mouse ascitic carcinoma cells after intraperitoneal chemotherapy with cisplatinum].
Kurokawa T; Tamakuma S; Ohsaki Y
Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1447-53. PubMed ID: 2809375
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor effect of polysaccharide lentinan on C3H/He mice bearing MH134 ascites hepatoma].
Moriyama M; Miwa H; Moriya N; Orita K
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1102-7. PubMed ID: 6820909
[TBL] [Abstract][Full Text] [Related]
4. [Clinical effects and immunological analysis of intraabdominal and intrapleural injection of lentinan for malignant ascites and pleural effusion of gastric carcinoma].
Hazama S; Oka M; Yoshino S; Iizuka N; Wadamori K; Yamamoto K; Hirazawa K; Wang F; Ogura Y; Masaki Y
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1595-7. PubMed ID: 7574768
[TBL] [Abstract][Full Text] [Related]
5. [Antitumor effect of bacterial lipopolysaccharide (LPS) and a combination use of LPS and lentinan on C3H/He mice bearing MH-134 tumor].
Moriya N; Miwa H; Taketsuka S; Orita K
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1646-52. PubMed ID: 6870308
[TBL] [Abstract][Full Text] [Related]
6. [Intraperitoneal administration of FT-207 for mouse peritonitis carcinomatosa].
Kurokawa T; Iwasa H; Mimura K; Terashima H; Hiraide H; Mizoguchi O; Kanabe S; Tamaki K; Kadota T; Hatsuse K
Gan To Kagaku Ryoho; 1984 Apr; 11(4):881-7. PubMed ID: 6426398
[TBL] [Abstract][Full Text] [Related]
7. Lentinan confers protection against type 1 diabetes by inducing regulatory T cell in spontaneous non-obese diabetic mice.
Wu T; Cai Z; Niu F; Qian B; Sun P; Yang N; Pang J; Mei H; Chang X; Chen F; Zhu Y; Li Y; Wu FG; Zhang Y; Lei T; Han X
Nutr Diabetes; 2023 Apr; 13(1):4. PubMed ID: 37031163
[TBL] [Abstract][Full Text] [Related]
8. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].
Taguchi T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):387-93. PubMed ID: 6349538
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
Suga T; Shiio T; Maeda YY; Chihara G
Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173
[TBL] [Abstract][Full Text] [Related]
10. Protective activity of Lentinan in experimental tuberculosis.
Markova N; Kussovski V; Drandarska I; Nikolaeva S; Georgieva N; Radoucheva T
Int Immunopharmacol; 2003 Oct; 3(10-11):1557-62. PubMed ID: 12946453
[TBL] [Abstract][Full Text] [Related]
11. [Combined use of lentinan with X-ray therapy in an experimental mouse tumor system (Part 2). Combined effect on the MM102 syngeneic tumor].
Shiio T; Ohishi K; Tsuchiya Y; Niitsu I; Hayashibara H; Yoshihama T; Moriyuki H
Gan To Kagaku Ryoho; 1988 Mar; 15(3):475-9. PubMed ID: 3348633
[TBL] [Abstract][Full Text] [Related]
12. [Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions].
Akimoto M; Nishihira T; Kasai M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1270-6. PubMed ID: 3729450
[TBL] [Abstract][Full Text] [Related]
13. [Synergistic action of lentinan (LNT) with endocrine therapy of breast cancer in rats and humans].
Kosaka A; Kuzuoka M; Yamafuji K; Imaizumi A; Hattori Y; Yamashita A
Gan To Kagaku Ryoho; 1987 Feb; 14(2):516-22. PubMed ID: 3101609
[TBL] [Abstract][Full Text] [Related]
14. [Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments].
Akimoto M; Nishihira T; Mori S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):827-33. PubMed ID: 3260467
[TBL] [Abstract][Full Text] [Related]
15. [Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group].
Wakui A; Kasai M; Konno K; Abe R; Kanamaru R; Takahashi K; Nakai Y; Yoshida Y; Koie H; Masuda H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1050-9. PubMed ID: 3083785
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the omental lymphoid organ in the induction of peritoneal immunity against tumor cells.
Dullens HF; Rademakers LH; Doffemont M; Van Veen PT; Bulder R; Den Otter W
Invasion Metastasis; 1993; 13(5):267-76. PubMed ID: 7960579
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey.
Taguchi T
Cancer Detect Prev Suppl; 1987; 1():333-49. PubMed ID: 3121179
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody.
Luo JC; Toyoda M; Shibuya M
Cancer Res; 1998 Jun; 58(12):2594-600. PubMed ID: 9635584
[TBL] [Abstract][Full Text] [Related]
19. Combination antitumor therapy with lentinan and bacterial lipopolysaccharide against murine tumors.
Abe S; Yoshioka O; Masuko Y; Tsubouchi J; Kohno M; Nakajima H; Yamazaki M; Mizono D
Gan; 1982 Feb; 73(1):91-6. PubMed ID: 6749591
[TBL] [Abstract][Full Text] [Related]
20. Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors.
Gatanaga T; Takahashi K; Yamazaki M; Mizuno D; Abe S
Jpn J Cancer Res; 1985 Jul; 76(7):631-6. PubMed ID: 3928560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
